Systemic inflammation, mediated by cytokines like interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and the activation of the NLRP3 inflammasome, plays a pivotal role in the progression of CRS. This evidence concerns the gene NLRP3 and congenital rubella syndrome.